
Dren Bio Stock
Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.
Sign up today and learn more about Dren Bio Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Dren Bio Stock
Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
Funding History
July 2019 | $5.1M |
---|---|
October 2020 | $60.0M |
March 2022 | $62.5M |
Management
CEO and Co-Fonder
Nenad Tomasevic
Co-Founder, CFO
John Wesley
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase